当前位置:首页 - 行情中心 - 科前生物(688526) - 财务分析 - 现金流量表

科前生物

(688526)

  

流通市值:83.95亿  总市值:83.95亿
流通股本:4.66亿   总股本:4.66亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金476,305,454.78309,746,735.75817,089,733.63636,729,841.36
  收到的税费返还32,964.2612,164.26157,9500
  收到其他与经营活动有关的现金11,996,849.975,943,794.2463,247,494.1747,341,683.17
  经营活动现金流入小计488,335,269.01315,702,694.25880,495,177.8684,071,524.53
  购买商品、接受劳务支付的现金94,332,970.1342,192,911.6278,130,184.63101,995,075.83
  支付给职工以及为职工支付的现金114,623,639.1977,559,715.9185,785,154.68149,035,636.83
  支付的各项税费55,751,626.5227,449,656.32110,009,163.888,189,249.37
  支付其他与经营活动有关的现金49,301,038.4928,462,575.08113,888,862.3771,760,685.7
  经营活动现金流出小计314,009,274.33175,664,858.92487,813,365.48410,980,647.73
  经营活动产生的现金流量净额174,325,994.68140,037,835.33392,681,812.32273,090,876.8
二、投资活动产生的现金流量:
  收回投资收到的现金594,435,398179,403,398.721,334,010,235.29913,836,754.68
  取得投资收益收到的现金79,606,617.345,190,049.0739,778,947.6726,005,092.42
  处置固定资产、无形资产和其他长期资产收回的现金净额--2,590,308.98-
  投资活动现金流入小计674,042,015.34184,593,447.791,376,379,491.94939,841,847.1
  购建固定资产、无形资产和其他长期资产支付的现金31,261,572.4618,630,674.56106,943,665.4728,740,287.57
  投资支付的现金575,299,930.56246,500,0001,172,848,565.64877,513,212.43
  取得子公司及其他营业单位支付的现金4,500,000---
  支付其他与投资活动有关的现金2,140,368.361,938,639.27-5,306,828.8
  投资活动现金流出小计613,201,871.38267,069,313.831,279,792,231.11911,560,328.8
  投资活动产生的现金流量净额60,840,143.96-82,475,866.0496,587,260.8328,281,518.3
三、筹资活动产生的现金流量:
  吸收投资收到的现金17,692,584-420,000-
  其中:子公司吸收少数股东投资收到的现金--420,000-
  取得借款收到的现金0-97,000,00097,000,000
  收到其他与筹资活动有关的现金--24,371,961.57-
  筹资活动现金流入平衡项目0-00
  筹资活动现金流入小计17,692,584-121,791,961.5797,000,000
  偿还债务支付的现金--383,490,000326,490,000
  分配股利、利润或偿付利息支付的现金199,543,845.81-204,581,160.88204,341,416.59
  支付其他与筹资活动有关的现金1,463,470.571,105,814.6936,897,792.8931,394,768.04
  筹资活动现金流出小计201,007,316.381,105,814.69624,968,953.77562,226,184.63
  筹资活动产生的现金流量净额-183,314,732.38-1,105,814.69-503,176,992.2-465,226,184.63
四、汇率变动对现金及现金等价物的影响-505,291.59-7,459.4917,728.85-11,538.76
五、现金及现金等价物净增加额51,346,114.6756,448,695.11-13,890,190.2-163,865,328.29
  加:期初现金及现金等价物余额543,478,592.74543,478,592.74557,368,782.94557,368,782.94
  期末现金及现金等价物余额594,824,707.41599,927,287.85543,478,592.74393,503,454.65
补充资料:
  净利润219,277,761.2-381,489,646.31-
  资产减值准备-671,363.37-16,080,317.97-
  固定资产和投资性房地产折旧53,534,989.63-104,346,863.65-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧53,534,989.63-104,346,863.65-
  无形资产摊销2,116,186.86-3,877,828.28-
  长期待摊费用摊销236,767.88-334,686.68-
  处置固定资产、无形资产和其他长期资产的损失0-333,145.98-
  固定资产报废损失144,434.38-371.6-
  公允价值变动损失-13,267,119.68--30,986,081.97-
  财务费用-24,882,373.92--45,882,480.59-
  投资损失-3,572,559.49--6,616,220.42-
  递延所得税507,482.27-4,084,277.72-
  其中:递延所得税资产减少289,028--659,344.95-
    递延所得税负债增加218,454.27-4,743,622.67-
  存货的减少-18,216,509.56-6,430,837.51-
  经营性应收项目的减少23,348,348.61--20,402,448.26-
  经营性应付项目的增加-65,855,826.48--34,071,634.32-
  融资租入固定资产--1,388,458.03-
  现金的期末余额594,824,707.41-543,478,592.74-
  减:现金的期初余额543,478,592.74-557,368,782.94-
  现金及现金等价物的净增加额51,346,114.67--13,890,190.2-
公告日期2025-08-262025-04-292025-04-292024-10-31
审计意见(境内)标准无保留意见
TOP↑